AVEO PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2021.
  • Aveo Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.49M, a 6.07% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $5.53M, a 25.2% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.14M, a 118% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.36M, a 0.13% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $2.36M, a 7.38% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $5.14M +$2.79M +118% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-14
2020 $2.36M -$3K -0.13% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $2.36M -$188K -7.38% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $2.55M +$1.46M +134% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 $1.09M +$90K +9.01% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $999K -$133K -11.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $1.13M -$1.68M -59.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 $2.81M -$1.13M -28.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-22
2013 $3.94M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.